Open-label Phase 2a study of AG-73305, a novel bi-specific Fc-fusion protein for the treatment of diabetic macular edema

AG-73305 - Allgenesis Biotherap

Avastin (bevacizumab) - Roche

Sunil Patel 1; Janet K. Cheetham 2; Tan Nguyen 1; David S. Boyer 3; Artemis Wu 1; Ben Chang 1; Larry A. Wheeler 4; Madhu Cherukury 1

Apr 6, 2023